ArticleCancer biology & therapy2012

K-Ras gene mutation status as a prognostic and predictive factor in patients with colorectal cancer undergoing irinotecan- or oxaliplatin-based chemotherapy.

Rafał Stec et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.